Dexcom announces the first Generative AI platform in glucose biosensing.…
Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose…
…
Dexcom shares up as Diabetes Association updates guidelines…
Tony Zhang describes selling a cash secured put in Dexcom.…
The major participants in the United Kingdom Diabetes Device market includes Abbott Laboratories, Roche, Medtronic, Novo Nordisk A/S, Terumo Corporation,…
SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP investigates potential violations of federal and state…
Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The companys shares are down sharply year to…
Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies arent automatically worth investing in…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although its not a part of…
Its not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock market…
DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet, exercise and overall well-being.…
Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.…
Dow drops 0.86%, S&P 500 slips below 6,000 while Nasdaq shows resilience. Amgen leads decliners, Dexcom tops gainers in mixed…
Am US-amerikanischen Aktienmarkt notiert die Aktie von Dexcom zur Stunde ein wenig fester. Die Aktie kostete zuletzt 70,61 US-Dollar. Die…
S&P 500 poised for weekly drop, Capri Holdings stock plummets on blocked Tapestry merger: Yahoo FinanceThe S&P 500 (^GSPC) is…
DXCM earnings call for the period ending September 30, 2024.…
DXCMs third-quarter 2024 earnings and revenues surpass expectations, fueled by global growth in CGM adoption, strong Sensor sales and expansion…
…
These are the stocks posting the largest moves in extended trading.…
Dexcom shares fell on Thursday after the company released third-quarter results that showed slow revenue growth…
After-hours movers: Capri Holdings, Skechers, DexCom, Western Digital and more…
DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth…
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Die DexCom Aktie verzeichnete am 19. Oktober einen deutlichen Kursanstieg von 4,07% auf 72,38 USD. Dieser positive Trend setzt sich…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…
ATLANTA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the October 21, 2024…
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
…
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…
RADNOR, Pa., Oct. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…
NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Is DexComs business in trouble, or could this be a great buying opportunity for investors?…
Is DexComs business in trouble, or could this be a great buying opportunity for investors?…
NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, Oct. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…
Im Plus liegt aktuell der Anteilsschein von Dexcom . Zuletzt zahlten Investoren für das Papier 68,44 US-Dollar. Eine Verteuerung in…
RADNOR, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…
Demand for blood glucose monitors is strong, but DexCom isnt the only competitor in this lucrative market.…
Demand for blood glucose monitors is strong, but DexCom isnt the only competitor in this lucrative market.…
NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the…
DXCM continues to raise optimism among investors, owing to its strong product portfolio.…
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline…